Early kinetics of C-reactive protein predicts oncological outcome of patients with metastatic renal cell carcinoma under first-line therapy with immune checkpoint inhibitors

被引：0
作者：
Schuettke, V [1 ]
Kusiek, C. [1 ]
Mehralivand, S. [1 ]
Buerk, B. T. [1 ]
Thomas, C. [1 ]
Fuessel, S. [1 ]
Erdmann, K. [1 ]
机构：
[1] Tech Univ Dresden, Dept Urol, Dresden, Germany
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A1031
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma
    Wells, J. Connor
    Graham, Jeffrey
    Beuselinck, Benoit
    Bjarnason, Georg A.
    Donskov, Frede
    Hansen, Aaron R.
    McKay, Rana R.
    Vaishampayan, Ulka
    De Velasco, Guillermo
    Duh, Mei S.
    Huynh, Lynn
    Nguyen, Catherine
    Zanotti, Giovanni
    Ramaswamy, Krishnan
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (04) : E350 - E359
  • [32] Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
    Derosa, Lisa
    Routy, Bertrand
    Enot, David
    Baciarello, Giulia
    Massard, Christophe
    Loriot, Yohann
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [33] Prognostic impact of C-reactive protein response in patients with metastatic renal cell carcinoma
    Saito, Kazutaka
    Tatokoro, Manabu
    Limura, Yasumasa
    Fujii, Yasuhisa
    Akai, Yasuyuki
    Koga, Fumitaka
    Kobayashi, Tsuyoshi
    Kawakami, Satoru
    Kihara, Kazunori
    JOURNAL OF UROLOGY, 2008, 179 (04) : 167 - 168
  • [34] Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
    Fukuda, Shohei
    Saito, Kazutaka
    Yasuda, Yosuke
    Kijima, Toshiki
    Yoshida, Soichiro
    Yokoyama, Minato
    Ishioka, Junichiro
    Matsuoka, Yoh
    Kageyama, Yukio
    Fujii, Yasuhisa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
  • [35] First-Line Therapy of Metastatic Renal Cell Carcinoma - Update 2009
    Miller, Kurt
    ONKOLOGIE, 2010, 33 : 5 - 9
  • [36] Baseline high-sensitivity C-reactive protein to predict progression-free survival in metastatic renal cell carcinoma patients treated with first-line sunitinib
    Mizuno, Ryuichi
    Kimura, Go
    Kondo, Tsunenori
    Ueda, Takeshi
    Hara, Hidehiko
    Kishida, Takeshi
    Kume, Haruki
    Sohji, Sunao
    Hatano, Takashi
    Morita, Jun
    Kawata, Nozomu
    Matsumoto, Kazuhiro
    Ishida, Masaru
    Takahashi, Shunji
    Tanabe, Kazunari
    Nakazawa, Hayakazu
    Horie, Shigeo
    Oya, Mototsugu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
    Yu-Wei Chen
    Brian I. Rini
    Current Oncology Reports, 2022, 24 : 695 - 702
  • [38] Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
    Chen, Yu-Wei
    Rini, Brian, I
    CURRENT ONCOLOGY REPORTS, 2022, 24 (06) : 695 - 702
  • [39] Relative risk of pneumonitis associated with first-line use of immune checkpoint inhibitors in advanced renal cell carcinoma
    Jahan, Nusrat
    Mogollon-Duffo, Francis
    Meda, Srikala
    Hardwicke, Fred L.
    Tijani, Lukman Aderoju
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [40] The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients
    Guo, Shengjie
    He, Xiaobo
    Chen, Qian
    Yang, Guangwei
    Yao, Kai
    Dong, Pei
    Ye, Yunlin
    Chen, Dong
    Zhang, Zhiling
    Qin, Zike
    Liu, Zhuowei
    Xue, Yunfei
    Zhang, Meng
    Liu, Ruiwu
    Zhou, Fangjian
    Han, Hui
    BMC CANCER, 2017, 17
12345